These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection. Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591 [TBL] [Abstract][Full Text] [Related]
8. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Stotland PK; Radzioch D; Stevenson MM Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433 [TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649 [TBL] [Abstract][Full Text] [Related]
10. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Day BJ; van Heeckeren AM; Min E; Velsor LW Infect Immun; 2004 Apr; 72(4):2045-51. PubMed ID: 15039325 [TBL] [Abstract][Full Text] [Related]
12. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [TBL] [Abstract][Full Text] [Related]
13. Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Bielen K; 's Jongers B; Boddaert J; Raju TK; Lammens C; Malhotra-Kumar S; Jorens PG; Goossens H; Kumar-Singh S Front Cell Infect Microbiol; 2017; 7():274. PubMed ID: 28680858 [TBL] [Abstract][Full Text] [Related]
14. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. van Heeckeren AM; Schluchter MD; Drumm ML; Davis PB Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L944-52. PubMed ID: 15246977 [TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694 [TBL] [Abstract][Full Text] [Related]
17. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation. Saadane A; Soltys J; Berger M J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347 [TBL] [Abstract][Full Text] [Related]
18. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Yu H; Nasr SZ; Deretic V Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612 [TBL] [Abstract][Full Text] [Related]
19. Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells. Xu Y; Tertilt C; Krause A; Quadri LE; Crystal RG; Worgall S Respir Res; 2009 Apr; 10(1):26. PubMed ID: 19344509 [TBL] [Abstract][Full Text] [Related]
20. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]